Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
216 Cambridge Science Park , Milton Road, Cambridge , CB4 0WA
216 Cambridge Science Park
Amgen has a virtual first approach to work, empowering their workforce to work when and where they feel they can perform the most efficiently. There are three main flexible working categories, Working as Flexible commuters, working remotely and working primarily onsite; each giving choice to employees whilst also providing a healthy work-life balance.
What we love about Amgen:
💡 Amgen empowers its employees to decide where they work the most productively and have a healthy work-life balance.
💡 Those who work remotely can work anywhere within the country.
What is worth checking about Amgen:
💡 Some roles may require employees to work primarily onsite, for example, those who work in laboratories and manufacturing facilities.
Articles about Amgen:
Like many companies managing the impacts from the COVID-19 pandemic, a significant portion of Amgen employees began working from home in March 2020. Amgen CEO Bob Bradway recently sent a letter to employees explaining that, “after much reflection on the many lessons learned over the past year, we have decided that most site-based staff working from home today will continue to work from home for the majority of their time – even after the pandemic has ended.” The decision was supported by internal surveys showing that more than 80% of employees working virtually wanted to maintain that flexibility in the future.
This was a pivotal moment, an opportunity to reimagine the future of working at Amgen. The goal: empower a global workforce to work when and where they are most productive, while also providing the flexibility to achieve work-life balance. The priority for Amgen is to find the right balance of virtual and in-person work with the goal of delivering the best outcomes for individuals, teams and patients. The company will also continue to prioritize the safety of its employees and their families, which means that appropriate restrictions for on-site visitation and off-site meetings will be continually examined. Amgen has also required COVID-19 vaccination in the U.S. and Puerto Rico.
Generally speaking, this new approach indentifies work arrangements falling into one of three categories:
Working as “Flexible Commuters”
“Flexible Commuters” are employees who primarily work virtually, but still have the opportunity to come to the office for work that benefits significantly from being face-to-face (such as for team meetings or to collaborate on projects). As these people may still need to come to a site or office occasionally, they should still live within a commutable distance of their Amgen site, and within their existing work country. Most Amgen employees who had been working virtually throughout the pandemic are continuing to operate with this “virtual first” mindset, as will new hires who fall into this category.
The shift to a “virtual first” way of working has created expanded opportunities for existing employees to become fully remote should they wish to move to a different location if they choose to do so (beyond a commutable distance from their designated Amgen site, but still within their existing work country). The company also remains open to remote work opportunities for potential employees.
Working Primarily Onsite
A select group of Amgen employees who work in laboratories, manufacturing facilities, and other areas have been working onsite throughout the pandemic, following comprehensive safety measures. The kind of work they do requires them to be on-site regularly. As safety conditions permit, site access will be expanded to include additional employees who could benefit from access to onsite equipment, technology and workspaces. While Amgen’s facilities and office spaces around the world will continue to be part of the company’s culture, the company will also preserve what has been learned throughout the pandemic by offering flexibility to onsite employees for activities that may be best completed virtually.